SIMCERE PHARMA: Next Day Disclosure Return
SIMCERE PHARMA: Next Day Disclosure Return
SIMCERE PHARMA: Next Day Disclosure Return
SIMCERE PHARMA: Next Day Disclosure Return
SIMCERE PHARMA: Next Day Disclosure Return
SIMCERE PHARMA: Letter to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
SIMCERE PHARMA: Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
SIMCERE PHARMA: ELECTION OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS
SIMCERE PHARMA: GRANT OF AWARDS UNDER THE 2021 RSU SCHEME
SIMCERE PHARMA: VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE
SIMCERE PHARMA: FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2023
SIMCERE PHARMA: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023
SIMCERE PHARMA: ADOPTION OF EQUITY INCENTIVE SCHEME BY SIMCERE ZAIMING AND CONNECTED TRANSACTION IN RELATION TO CAPITAL CONTRIBUTIONS IN SIMCERE ZAIMING
SIMCERE PHARMA: VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF SUVEMCITUG FOR INJECTION ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
SIMCERE PHARMA: VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR SIM0500 FOR INJECTION (A HUMANIZED GPRC5D-BCMA-CD3 TRISPECIFIC ANTIBODY) ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
SIMCERE PHARMA: VOLUNTARY ANNOUNCEMENT - APPROVAL OF THE INVESTIGATIONAL NEW DRUG FOR SIM0500 (A HUMANIZED GPRC5D-BCMA-CD3 TRISPECIFIC ANTIBODY) ISSUED BY U.S. FOOD AND DRUG ADMINISTRATION
SIMCERE PHARMA: DATE OF BOARD MEETING
SIMCERE PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
SIMCERE PHARMA: DISCLOSEABLE TRANSACTION IN RELATION TO DEEMED DISPOSAL OF EQUITY INTEREST IN SIMCERE ZAIMING
SIMCERE PHARMA: VOLUNTARY ANNOUNCEMENT - PUBLICATION BY JAMA NEUROLOGY ABOUT THE PHASE III CLINICAL STUDIES RESULTS OF SANBEXIN SUBLINGUAL TABLETS FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE
No Data